UnitedHealthcare Cuts Prior Auth Requirements by Nearly a Third — But the Real Impact Depends on What's Actually on the List

In early May, UnitedHealthcare (UHC) announced plans to eliminate prior authorization requirements for roughly 30% of services currently requiring advance approval, phased in by year-end.

According to the company’s press release, the eliminations will include “select outpatient surgeries, some diagnostic tests like echocardiograms, and certain outpatient therapies and chiropractic care,” with a full list to come.

UHC says it currently requires prior authorization for 2% of medical services. The move to cut parallels similar pledges from other insurers as part of a multi-year voluntary commitment with HHS and CMS.

The real question is whether these moves amount to a substantial change or a PR move.

If the list skews toward chiropractic, low-cost outpatient therapy, and routine diagnostics — as some suspect it will — the 30% number is mostly optics. On the other hand, if it includes meaningful chunks of specialty imaging, surgical procedures, or expensive drugs, it could actually move the needle for providers. The volume and cost of claims affected will be more important than the topline service count.

Weeks earlier, UHC also announced that it would eliminate most prior auth requirements for rural providers. Likely applicable to a wider range of services, this may be more impactful in practice, given that rural hospitals tend to operate on thin margins where reduced administrative burden could have a proportionally larger effect.

The emphasis on outpatient services is worth watching.

By removing pre-approval friction from outpatient procedures while leaving inpatient utilization management largely intact, UHC is effectively widening the administrative gap between settings. A procedure in an ASC or office-based lab will move faster, with fewer denials and less revenue-cycle drag, than the same procedure performed inpatient. As payment policy continues moving toward site-neutrality, this could make it even harder for inpatient settings to compete with outpatient equivalents — and gives physicians yet another reason to prefer working in ASCs.

Finally, the timing reflects converging pressures.

The reputational fallout from the December 2024 killing of former CEO Brian Thompson put prior auth at the center of national debate, and regulatory pressure (The CMS Interoperability and Prior Authorization Final Rule took effect this year). And with Aetna, Cigna, Humana, and the major Blues all loosening in parallel, UHC can now follow suit without ceding competitive ground.

Selective contract drops by systems like Johns Hopkins Medicine, Brown University Health, and Lehigh Valley Health Network also give UHC incentive to ease the most visible operational frictions.

So What?

• The prior auth reduction does not mean demand for rev cycle solutions will decline — but it may shift. If high-volume, low-complexity authorizations come off the table, health system rev cycle teams can redirect bandwidth toward higher-value work: denial management, appeals, underpayment recovery. Partners should position around that shift.

• For rural systems specifically, prior auth relief could free up administrative capacity that was previously consumed by survival-mode processing. That creates an opening for partners who can help move rural rev cycle operations to optimization — a different conversation than the one some partners are having today.

• The outpatient emphasis compounds the ambulatory advantage. Removing administrative friction from outpatient settings while maintaining it for inpatient care potentially accelerates the site-of-care migration already driven by payment policy. Partners touching ambulatory workflow or outpatient revenue cycle should recognize this as a demand tailwind.